# A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Weekly Compared to Placebo in Chinese Adults With Overweight or Obesity

> **NCT07792954** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Pfizer** · enrollment: 300 (estimated)

## Conditions studied

- Obesity
- Overweight

## Interventions

- **DRUG:** Berobenatide
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07792954
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-01
- **Primary completion:** 2028-03-14
- **Final completion:** 2028-05-23
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07792954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07792954, "A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Weekly Compared to Placebo in Chinese Adults With Overweight or Obesity". Retrieved via MORVS 2026-11-22 from https://api.morvs.ai/clinical/NCT07792954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
